Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.

Saved in:
Bibliographic Details
Title: Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.
Authors: Nishri Y; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel., Vatarescu M; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel., Luz I; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel., Epstein L; Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Radiation Protection Department, Soreq Nuclear Research Center, Yavne, Israel.; Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel., Dumančić M; Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Del Mare S; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel., Shai A; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel., Schmidt M; Physics Laboratory, Alpha Tau Medical, Jerusalem, Israel., Deutsch L; Biostatistics Department, BioStats Statistical Consulting Ltd., Maccabim, Israel., Den RB; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.; Department of Radiation Oncology, Urology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States., Kelson I; School of Physics and Astronomy, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel., Keisari Y; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Arazi L; Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Cooks T; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel., Domankevich V; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.
Source: Frontiers in oncology [Front Oncol] 2022 Sep 27; Vol. 12, pp. 888100. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36237307
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nishri+Y%22">Nishri Y</searchLink>; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Vatarescu+M%22">Vatarescu M</searchLink>; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Luz+I%22">Luz I</searchLink>; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Epstein+L%22">Epstein L</searchLink>; Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.; Radiation Protection Department, Soreq Nuclear Research Center, Yavne, Israel.; Department of Biomedical Engineering, Faculty of Engineering, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Dumančić+M%22">Dumančić M</searchLink>; Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Del+Mare+S%22">Del Mare S</searchLink>; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Shai+A%22">Shai A</searchLink>; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Schmidt+M%22">Schmidt M</searchLink>; Physics Laboratory, Alpha Tau Medical, Jerusalem, Israel.<br /><searchLink fieldCode="AU" term="%22Deutsch+L%22">Deutsch L</searchLink>; Biostatistics Department, BioStats Statistical Consulting Ltd., Maccabim, Israel.<br /><searchLink fieldCode="AU" term="%22Den+RB%22">Den RB</searchLink>; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.; Department of Radiation Oncology, Urology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA, United States.<br /><searchLink fieldCode="AU" term="%22Kelson+I%22">Kelson I</searchLink>; School of Physics and Astronomy, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Keisari+Y%22">Keisari Y</searchLink>; Department of Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Arazi+L%22">Arazi L</searchLink>; Unit of Nuclear Engineering, Faculty of Engineering Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Cooks+T%22">Cooks T</searchLink>; The Shraga Segal Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.<br /><searchLink fieldCode="AU" term="%22Domankevich+V%22">Domankevich V</searchLink>; Translational Research Laboratory, Alpha Tau Medical, Jerusalem, Israel.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2022 Sep 27; Vol. 12, pp. 888100. <i>Date of Electronic Publication: </i>2022 Sep 27 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36237307
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2022.888100
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 888100
    Titles:
      – TitleFull: Diffusing alpha-emitters radiation therapy in combination with temozolomide or bevacizumab in human glioblastoma multiforme xenografts.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nishri Y
      – PersonEntity:
          Name:
            NameFull: Vatarescu M
      – PersonEntity:
          Name:
            NameFull: Luz I
      – PersonEntity:
          Name:
            NameFull: Epstein L
      – PersonEntity:
          Name:
            NameFull: Dumančić M
      – PersonEntity:
          Name:
            NameFull: Del Mare S
      – PersonEntity:
          Name:
            NameFull: Shai A
      – PersonEntity:
          Name:
            NameFull: Schmidt M
      – PersonEntity:
          Name:
            NameFull: Deutsch L
      – PersonEntity:
          Name:
            NameFull: Den RB
      – PersonEntity:
          Name:
            NameFull: Kelson I
      – PersonEntity:
          Name:
            NameFull: Keisari Y
      – PersonEntity:
          Name:
            NameFull: Arazi L
      – PersonEntity:
          Name:
            NameFull: Cooks T
      – PersonEntity:
          Name:
            NameFull: Domankevich V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 09
              Text: 2022 Sep 27
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1